Breast Pathology

2020 Edition
| Editors: Anna Sapino, Janina Kulka

Atypical Vascular Lesions

  • Lauren E. Rosen
  • Thomas KrauszEmail author
Reference work entry


Cutaneous atypical vascular lesions (AVLs) of the breast have been described using a variety of terms including post-mastectomy lymphangiomatosis, benign lymphangiomatous papules, benign lymphangioendothelioma, acquired lymphangiectasis, and lymphangioma circumscriptum (Baker and Schnitt 2017; Weaver and Billings 2009).


AVLs are benign vascular proliferations of the skin that occur following radiation therapy for breast cancer within the field of radiation. The term AVL was proposed by Fineberg and Rosen in 1994 to reflect the fact that these lesions were occasionally mistaken for angiosarcoma, and because their relationship to post-irradiation angiosarcomas (PIAS) is not fully understood (Fineberg and Rosen 1994).

Clinical Features

  • Incidence

    AVLs occur in the field of radiation after radiation therapy for breast cancer, with a latency period of 1 month to 20 years, occurring most frequently between 3 and 6 years post-treatment (Ginter et al. 2017).

  • Age

    AVLs are...

This is a preview of subscription content, log in to check access.


  1. Baker, G. M., & Schnitt, S. J. (2017). Vascular lesions of the breast. Seminars in Diagnostic Pathology, 34, 410–419.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Brenn, T., & Fletcher, C. D. M. (2005). Radiation-associated cutaneous atypical vascular lesions and angiosarcoma. Clinicopathologic analysis of 42 cases. American Journal of Surgical Pathology, 29, 983–996.PubMedPubMedCentralGoogle Scholar
  3. Cornejo, K. M., Deng, A., Wu, H., et al. (2015). The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast. Human Pathology, 46, 868–875.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Fernandez, A. P., Sun, Y., Tubbs, R. R., et al. (2012). FISH for MYC amplification and anti-MYC immunohistochemistry: Useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. Journal of Cutaneous Pathology, 39, 234–242.PubMedCrossRefPubMedCentralGoogle Scholar
  5. Fineberg, S., & Rosen, P. P. (1994). Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. American Journal of Clinical Pathology, 102, 757–763.PubMedCrossRefPubMedCentralGoogle Scholar
  6. Flucke, U., Requena, L., & Mentzel, T. (2013). Radiation-induced vascular lesions of the skin: An overview. Advance in Anatomic Pathology, 20, 407–415.CrossRefGoogle Scholar
  7. Fraga-Guedes, C., Andre, S., Mastropasqua, M. G., et al. (2015). Angiosarcoma and atypical vascular lesions of the breast: Diagnostic and prognostic role of MYC gene amplification and protein expression. Breast Cancer Research Treatment, 151, 131–140.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Gengler, C., Coindre, J. M., Leroux, A., et al. (2007). Vascular proliferation of the skin after radiation therapy for breast cancer: Clinicopathologic analysis of a series in favor of a benign process: A study from the French sarcoma group. Cancer, 109, 1584–1598.PubMedCrossRefPubMedCentralGoogle Scholar
  9. Ginter, P. S., McIntire, P. J., & Shin, S. J. (2017). Vascular tumours of the breast: A comprehensive review with focus on diagnostic challenges encountered in the core biopsy setting. Pathology, 49, 197–214.PubMedCrossRefPubMedCentralGoogle Scholar
  10. Guo, T., Zhang, L., Change, N. E., et al. (2011). Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes, Chromosomes & Cancer, 50, 25–33.CrossRefGoogle Scholar
  11. Koerner, F. C. (2014). Sarcoma. In S. A. Hoda, E. Brogi, F. C. Koerner, & P. P. Rosen (Eds.), Rosen’s breast pathology (pp. 1143–1148). Philadelphia: Lippincott Williams & Wilkins.Google Scholar
  12. Mentzel, T., Schildhaus, H. U., Palmedo, G., et al. (2012). Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: Clinicopathological, immunohistochemical and molecular analysis of 66 cases. Modern Pathology, 25, 75–85.PubMedCrossRefPubMedCentralGoogle Scholar
  13. Patton, K. T., Deyrup, A. T., & Weiss, S. W. (2008). Atypical vascular lesions after surgery and radiation of the breast. A clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. American Journal of Surgical Pathology, 32, 943–950.PubMedCrossRefPubMedCentralGoogle Scholar
  14. Requena, L., Kutzner, H., Mentzel, T., et al. (2002). Benign vascular proliferations in irradiated skin. American Journal of Surgical Pathology, 26, 328–337.PubMedCrossRefPubMedCentralGoogle Scholar
  15. Santi, R., Cetica, V., Franchi, A., et al. (2011). Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast following radiotherapy. Histopathology, 58, 455–466.PubMedCrossRefPubMedCentralGoogle Scholar
  16. Udager, A. M., Ishikawa, M. K., Lucas, D. R., et al. (2016). MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: Practical considerations based on a single institutional experience. Pathology, 47, 697–704.CrossRefGoogle Scholar
  17. Weaver, J., & Billings, S. D. (2009). Postradiation cutaneous vascular tumors of the breast: A review. Seminars in Diagnostic Pathology, 26, 141–149.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of PathologyUniversity of ChicagoChicagoUSA